TrialAnti-cancer drugs2009

A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study.

Primo N Lara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.